EN
HI
Mankind Pharma Chart
Mankind Pharma Share Key Metrics
Volume
4.85 L
Market Cap
99659.40 CR
LTQ@LTP
25@2414.20
ATP
2416.25
Var Margin
14.52 %
Circuit Range
2165.4-2646.6
Delivery %
49.6 %
Value
117.14 CR
ASM/GSM
No
Market Lot
1
Summary
Mankind Pharma share price is ₹2414.2 as of 22 Jun, 2026. The stock Mankind Pharma intraday movement has stayed between ₹2395.00 and ₹2430.00, while on a 52-week basis,Mankind Pharma price 52 week high is ₹2716.50 & its 52 week low is ₹1909.70.
In terms of trading activity, Mankind Pharma has recorded a volume of 484809 shares, The Mankind Pharma has a market cap of ₹412805072 CR. The stock’s Average Traded Price (ATP) stands at ₹2416.25, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 25 @ ₹2414.20.
Mankind Pharma operates within a circuit range of ₹2165.40 – ₹2646.60, with a Value of ₹117.14 CR. The Delivery Percentage for the day is 49.6%. Additionally, Mankind Pharma currently falls under the No framework, and trades with a market lot size of 1.
Mankind Pharma Fundamentals
P/E Ratio
52.19
P/B Ratio
6.12
Div. Yield
0
Sector P/E
69.22
Sector P/B
3.06
Sec. Div. Yield
0.53
Mankind Pharma Resistance and Support
Pivot 2393.43
Resistance
First Resistance
2422.46
Second Resistance
2438.93
Third Resistance
2467.96
Support
First Support
2376.96
Second Support
2347.93
Third Support
2331.46
Mankind Pharma Futures & Options
Mankind Pharma Option Chain
View Price, OI, Greeks & More...
30JUN26
2418.00
6.90 (0.29%)
28JUL26
2427.90
8.40 (0.35%)
25AUG26
2434.20
3.60 (0.15%)
MANKIND|30JUN26 CE 2400.00
48.30
-3.55 (-6.85%)
MANKIND|30JUN26 PE 2420.00
42.15
-7.3 (-14.76%)
Mankind Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-19 | Audited Results |
| 2026-02-03 | Quarterly Results |
| 2025-11-06 | Quarterly Results |
| 2025-07-31 | Quarterly Results & Interim Dividend |
| 2025-05-21 | Audited Results |
| 2025-01-23 | Quarterly Results |
Mankind Pharma News
Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Change in Management
Mankind Pharma appointed Nilesh Kulkarni as the new Head of Human Resource Functions for the Group, designated as Senior Management Personnel, effective June 8, 2026. This change is part of an internal organizational restructuring.
Jun 08 2026 22:22:06
Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Mankind Pharma management will attend investor conferences in Mumbai on June 1 and June 2, 2026. Discussions will focus on the general business outlook, with no unpublished price sensitive information to be disclosed.
May 27 2026 16:14:36
Mankind Pharma Management
| Name | Position |
|---|---|
| Hitesh Kumar Jain | Company Secretary & Compliance Officer |
| Ramesh Juneja | Chairman |
Mankind Pharma Similar Stocks
Cipla Ltd.
1351.80
-3.70 (0.27%)
Zydus Lifesciences Ltd.
1070.80
-3.60 (0.34%)
Dr. Reddy's Laboratories Ltd.
1272.10
4.60 (0.36%)
Lupin Ltd.
2351.60
24.50 (1.05%)
Max Healthcare Institute Ltd.
1094.75
4.30 (0.39%)
Lenskart Solutions Ltd.
511.95
6.90 (1.37%)
Aurobindo Pharma Ltd.
1497.80
54.10 (3.75%)
Laurus Labs Ltd.
1412.90
44.10 (3.22%)
Fortis Healthcare Ltd.
962.95
4.20 (0.44%)
Biocon Ltd.
415.50
1.65 (0.40%)
Mankind Pharma FAQs
The Buying Price of Mankind Pharma share is 2414.2 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Mankind Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Mankind Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Mankind Pharma shares is 52.19. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Mankind Pharma shares is 6.12. Useful to assess the stock's value relative to its book value.
To assess Mankind Pharma’s valuation compare Sector P/E, P/B which are 69.22 & 3.06 with sector averages, along with growth rates and financial metrics.
The Market Cap of Mankind Pharma is 99659.40 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Mankind Pharma share price is 2716.50 & 1909.70. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Mankind Pharma belongs to the Healthcare sector.
Made for Traders.
Trusted by Investors.
Download FinX — trade confidently, invest
smarter, track everything.
